| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9441 |
| Human Intestinal Absorption | HIA+ | 0.9896 |
| Caco-2 Permeability | Caco2+ | 0.6578 |
| P-glycoprotein Substrate | Substrate | 0.6031 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5711 |
| Non-inhibitor | 0.8629 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8357 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8677 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8633 |
| CYP450 2D6 Substrate | Non-substrate | 0.8538 |
| CYP450 3A4 Substrate | Non-substrate | 0.5984 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5930 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7722 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8852 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6179 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8664 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8100 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9107 |
| Non-inhibitor | 0.7564 |
| AMES Toxicity | Non AMES toxic | 0.7902 |
| Carcinogens | Non-carcinogens | 0.8036 |
| Fish Toxicity | High FHMT | 0.9921 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9996 |
| Honey Bee Toxicity | Low HBT | 0.5270 |
| Biodegradation | Ready biodegradable | 0.8296 |
| Acute Oral Toxicity | IV | 0.6396 |
| Carcinogenicity (Three-class) | Warning | 0.5129 |